[1] |
王津燕. 中药黄芩药理作用的研究进展[J]. 内蒙古中医药, 2020, 39(2):167-168.
|
[2] |
国家卫生健康委办公厅, 国家中医药管理办公室. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第八版)的通知[Z]. 2020.
|
[3] |
杨志华, 闫海峰, 闫艳芳, 等. 基于网络药理学探讨双黄连口服液抑制新型冠状病毒(2019-nCoV)的分子机制研究[J]. 中药材, 2020(9):2333-2340.
|
[4] |
LU Gejin, XU Lei, ZHANG Tong, et al. A potential bio-control agent from baical skullcap root against listeriosis via the inhibition of sortase A and listeriolysin O[J]. Journal of cellular and molecular medicine, 2019, 23(3).
|
[5] |
王文涛, 陈瑞, 曹瑶, 等. 中药黄芩资源研究进展[J]. 陕西农业科学, 2019, 65(4):87-91.
|
[6] |
BAI Chengke, YANG Jingjing, CAO Bo, et al. Growth years and post-harvest processing methods have critical roles on the contents of medicinal active ingredients of Scutellaria baicalensis[J]. Industrial crops and products, 2020, 158.
|
[7] |
SONG Lijun, ZHONG Peicheng, ZHU Xuemei, et al. The anti-rotavirus effect of baicalin via the gluconeogenesis-related p-JNK-PDK1-AKT-SIK2 signaling pathway[J]. European journal of pharmacology, 2021, 897.
|
[8] |
QIAO Xue, LI Ru, SONG Wei, et al. A targeted strategy to analyze untargeted mass spectral data: Rapid chemical profiling of Scutellaria baicalensis using ultra-high performance liquid chromatography coupled with hybrid quadrupole orbitrap mass spectrometry and key ion filtering[J]. Journal of chromatography A, 2016, 1441.
|
[9] |
YU Xiu, CHEN Dandan, WANG Lingwei, et al. Wogonoside inhibits inflammatory cytokine production in lipopolysaccharide-stimulated macrophage by suppressing the activation of the JNK/c-Jun signaling pathway[J]. Annals of translational medicine, 2020, 8(8).
|
[10] |
HUYNH Do Luong, NGAU Tran Hoang, NGUYEN Nguyen Hoai, et al. Potential therapeutic and pharmacological effects of Wogonin: An updated review[J]. Molecular biology reports, 2020, 47(12).
|
[11] |
刘梦珂, 纪濛濛, 程林, 等. 黄芩苷抗肿瘤作用机制的研究进展[J]. 上海交通大学学报:医学版, 2021, 41(2):1674-8115.
|
[12] |
JIANG Guangyu, CHEN Dayin, LI Wenpeng, et al. Effects of wogonoside on the inflammatory response and oxidative stress in mice with nonalcoholic fatty liver disease[J]. Pharmaceutical biology, 2020, 58(1).
|
[13] |
WANG Chaoyue, ZUO Guanglei, WANG Xiang, et al. Retention mechanism of pH-peak-focusing in countercurrent chromatographic separation of baicalin and wogonoside from Scutellaria baicalensis Georgi[J]. Journal of separation science, 2020, 43(19).
|
[14] |
刘青青, 王玉波, 刘建伟, 等. 同时测定黄芩提取液中黄芩苷、汉黄芩苷、黄芩素含量的高效液相色谱方法的建立[J]. 滨州医学院学报, 2020, 43(1):54-57.
|
[15] |
CHENG Yingqiu, LI Shipeng, LIU Yi, et al. Treatment of brain edema by wogonoside is associated with inhibition of neuronal apoptosis and SIRT1 activation in rats[J]. Medical science monitor, 2020, 26.
|
[16] |
HUANG Yujie, FANG Jiansong, LU Weiqiang, et al. A systems pharmacology approach uncovers wogonoside as an angiogenesis inhibitor of triple-negative breast cancer by targeting hedgehog signaling[J]. Cell chemical biology, 2019, 26(8).
|
[17] |
廉政君, 常炜. 汉黄芩素调节JAK/STAT信号通路并诱导肺癌A549细胞凋亡及周期阻滞的作用及机制研究[J]. 临床肺科杂志, 2021, 26(2):270-274,279.
|
[18] |
JI Yeongseon, HAN Jin, LEE Nayoung, et al. Neuroprotective effects of baicalein, wogonin, and oroxylin A on amyloid beta-Induced toxicity via NF-κB/MAPK pathway modulation[J]. Molecules, 2020, 25(21).
|
[19] |
白荣, 白洪越, 孔水仙, 等. 汉黄芩素和汉黄芩苷对UGT1A1体外抑制活性的比较研究[J]. 中国中医药科技, 2020, 27(5):707-711.
|
[20] |
杨洋, 王志强, 任丽丽, 等. 不同产地黄芩药材中主要药效成分含量变化规律研究[J]. 天津中医药大学学报, 2020, 39(3):324-329.
|
[21] |
王林, 吴翠芸, 汪贤竹, 等. 黄芩苷对肺癌A549细胞自噬及上皮间质转化的影响[J]. 中国细胞生物学学报, 2020, 42(11):1960-1968.
|
[22] |
CAO Xuexiao, YOU Guangjiao, LI Huanhuan, et al. Comparative investigation for rotten xylem (kuqin) and strip types (tiaoqin) of Scutellaria baicalensis Georgi based on fingerprinting and chemical pattern recognition[J]. Molecules, 2019, 24(13).
|
[23] |
田甜. 不同产地和生长年限黄芩质量评价及药理作用研究[D]. 杭州:浙江理工大学, 2018.
|
[24] |
王常瞵, 高鹏, 姜晶晶, 等. 中药黄芩指纹图谱研究进展[J]. 辽宁中医药大学学报, 2020, 22(4):82-86.
|
[25] |
中华人民共和国药典委员会. 中国药典一部[M]. 北京: 化学工业出版社, 2015:562-563.
|